Diagnostics (Nov 2024)

Clinical Feasibility of 5.0 T MRI/MRCP in Characterizing Pancreatic Cystic Lesions: Comparison with 3.0 T and MDCT

  • Huijia Zhao,
  • Qiang Xu,
  • Ruichen Gao,
  • Bohui Yin,
  • Gan Sun,
  • Ke Xue,
  • Yuxin Yang,
  • Enhui Li,
  • Liang Zhu,
  • Feng Feng,
  • Wenming Wu

DOI
https://doi.org/10.3390/diagnostics14212457
Journal volume & issue
Vol. 14, no. 21
p. 2457

Abstract

Read online

Objectives: To assess the feasibility of 5.0 T magnetic resonance imaging (MRI) in characterizing pancreatic cystic lesions (PCLs), compared with 3.0 T MRI and multidetector computed tomography (MDCT). Methods: Thirty-five patients with PCLs underwent 5.0 T MR alongside 3.0 T MR or MDCT. Two observers measured subjective and objective image quality scores. The consistency of two observers between 5.0 T and 3.0 T was calculated by intraclass correlation coefficients. The characteristics of PCLs and their specific diagnosis, as well as benignity/malignancy, were evaluated across MDCT, 3.0 T, and 5.0 T MRI. Results: The 5.0 T MR demonstrated significantly higher subjective image quality and SNR on T1WI compared to that in 3.0 T MR (p Conclusions: 5.0 T MRI exhibits certain superiority in delineating details of PCLs and in clinical diagnostic accuracy, outperforming MDCT and 3.0 T MRI while maintaining sufficient image quality.

Keywords